P.O. Box 50030 London, ON N6A 6H8 info@rett.ca (519) 474-6877

Priority Review by Health Canada

Just announced at the 2024 Ascend Rett National Conference, Health Canada has accepted regulatory applications from Acadia Pharmaceuticals for DayBue (Trofinetide), but has also been accepted for a priority review by Health Canada. We were honored to be… Read More

2023 IRSF Scientific Meeting Review

Dear Members:  It was a pleasure to attend the International Rett Syndrome Foundation (IRSF) scientific meeting held in Nashville June  5-7, 2023. The meeting consisted of both poster and oral presentation sessions and breakout discussions focused on basic,… Read More